Cluster Analysis to Specify the MELAS Genotype and Phenotype Must Consider Genetic Background Peculiarities and Disease Progression

References

1. 1.↵
   1. Alves CA,
   2. Zandifar A,
   3. Peterson JT, et al

   . MELAS: phenotype classification into classic-versus-atypical presentations. AJNR Am J Neuroradiol 2023;44:602–10 doi:10.3174/ajnr.A7837 pmid:37024306

   Abstract/FREE Full Text
2. 2.↵
   1. Hirano M,
   2. Ricci E,
   3. Koenigsberger MR, et al

   . Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992;2:125–35 doi:10.1016/0960-8966(92)90045-8 pmid:1422200

   CrossRefPubMed
3. 3.↵
   1. Yatsuga S,
   2. Povalko N,
   3. Nishioka J, et al

   ; Taro Matsuoka for MELAS Study Group in Japan. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta 2012;1820:619–24 doi:10.1016/j.bbagen.2011.03.015 pmid:21443929

   CrossRefPubMed
4. 4.↵
   1. Finsterer J

   . Toxicity of antiepileptic drugs to mitochondria. Handb Exp Pharmacol 2017;240:473–88 doi:10.1007/164_2016_2 pmid:27590225

   CrossRefPubMed